Massachusetts-based Moderna on a mission to have the greatest possible impact on health care through MRNA medicines, pioneering individualized medicine for cancer patients. The company is now developing combination respiratory vaccines, designed to fight the flu, COVID-19 and RSV. Moderna says it is also working on vaccines for HIV and malaria."So we're much more than a COVID company," Tracey Franklin, Moderna's chief human resources officer says. "We right now have 48 programs in development across vaccines, across therapeutic areas."Moderna reports minimal attrition since opening 12 years ago, but so many jobs that were just Massachusetts based are now global, so the company is in need of additional workers. "We're heavily hiring in manufacturing and operations right now," Franklin said. "To expand on our personalized cancer vaccine, but again, it's across the company."The new jobs will be located in Cambridge's Kendall Square and at its campus in Norwood, Massachusetts."We are excited to welcome about 2,000 people to our company," Franklin said. Massachusetts U.S. Senator Elizabeth Warren and other lawmakers have expressed concerns to Moderna over its proposal to charge as much as $130 per dose for its COVID-19 vaccines. Warren and others say the move could prolong the public health crisis, fearing COVID shots become unaffordable. Moderna said in a written statement that it is committed to pricing that reflects the value that COVID-19 vaccines bring to patients health care systems and society.The Massachusetts-based vaccine producer says COVID-19 shots will remain free for most.